1[1]Fedele L, Arcaini L, Vercellini P, et al. Serum CA-125 levels in the diagnosis of endometriosis recurrence. Obstet Gynecol, 1988,72:9～22
2[2]Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril, 1991, 55(4):759～65
3[4]Chen FP, Soong YK, Lee N, et al. The use ot serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand, 1998,77:665～670
4[5]Nagamani M, Kelver ME, Smith ER. CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence. Int J Fertil, 1992,37:227～231
5[6]Garzetti GG,Ciavattini A,Tranquilli AL,et al. Serum CA125 concerntration in Endometriosis patients:role of pelvic and peritoneal irritation. Gynecol Endocrinol,1994,8:27～31
6[7]Nieto A, Tacuri C, Serra M, et al. Long-term follow-up of endometriosis after two different therapies (Gestrinone and Buserelin). Clin Exp Obstet Gynecol,1996,23:198～204
7[8]Clayton RD, Hawe JA, Love JC, et al. Recurrent pain after hysterectomy and bilateral salpingo-oophorectomy for endometriosis: evaluation of laparoscopic excision of residual endometriosis. Br J Obstet Gynaecol, 1999, 106(7):740～744
8[9]Namnoum AB,Hickman TN,Goodman SB,et al. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril, 1995,64(5): 898～902
9[11]Regidor PA, Regidor M, Kato K, et al. Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome.Eur J Obstet Gynecol Reprod Biol, 1997,73(2):153～160
10[12]Muzii L, Marana R, Caruana P, et al. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Am J Obstet Gynecol, 2000,183:588～592
